Elsa L S A van Liere

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Mesenchymal Stem Cells

Colorectal Cancer Screening

Ulcerative Colitis

Top Venues

Alimentary pharmacology & therapeutics

Digestive diseases and sciences

The American journal of gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Elsa L S A van Liere, Nanne K H de Boer
Editorial: Towards optimal thiopurine therapy for inflammatory bowel disease. Alimentary pharmacology & therapeutics 59 (6) (2024)
Elsa L S A van Liere, Nanne K H de Boer
Editorial: Towards optimal thiopurine therapy for inflammatory bowel disease. Alimentary pharmacology & therapeutics 59 (6) (2024)
Elsa L S A van Liere, Nanne K H De Boer, Monique E van Leerdam, Evelien Dekker, Maarten A J M Jacobs, Jan Jacob Koornstra, Johan P Kuijvenhoven, Margriet Lemmens, Gerrit A Meijer, Manon C W Spaander, Beatriz Carvalho, Dewkoemar Ramsoekh
FECAL IMMUNOCHEMICAL TEST TO DETECT COLORECTAL NEOPLASIA IN LYNCH SYNDROME - A PROSPECTIVE MULTICENTER STUDY. The American journal of gastroenterology (2024)
Elsa L S A van Liere, Nanne K H de Boer, Evelien Dekker, Monique E van Leerdam, Tim G J de Meij, Dewkoemar Ramsoekh
Systematic review: non-endoscopic surveillance for colorectal neoplasia in individuals with Lynch syndrome. Alimentary pharmacology & therapeutics 55 (7) (2022)
Elsa L S A van Liere, Ahmed B Bayoumy, Chris J J Mulder, Ben Warner, Bu Hayee, Bilal A Mateen, Jonathan D Nolan, Nanne K H de Boer, Simon H C Anderson, Azhar R Ansari
Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases. Digestive diseases and sciences (2021)